Tag: OBES, ALCA

Risk score derived from cardiovascular reactivity predictive of adverse outcomes beyond traditional cardiovascular risk factors in CAD

U.S. Census sex-age adjustments improved clinical performance estimates

Approval is targeted for patients with HER2-low or HER2-ultralow metastatic breast cancer with disease progression after endocrine therapy

No increase reported in psychotherapy claims during pregnancy; medication fills returned to prepregancy levels within one month after birth

Significantly lower 15-year cumulative incidence of major adverse liver outcomes seen in those undergoing metabolic surgery

No evidence supports physical exertion without rhabdomyolysis or heat injury causing sudden death in sickle cell trait

Higher variability also linked to cognitive impairment with no dementia and with faster decline in global cognition, episodic memory

An eight-week, nonpharmacological intervention showed significant relationships with pain and biological outcomes

Protective effect more pronounced for ischemic stroke and in women with migraine without aura

TSCP yielded rate of hearing loss of 22 percent in Meniere disease, with no impact of disease duration or follow-up time

Glial fibrillary acidic protein concentrations strongly elevated in patients with intracerebral hemorrhage versus ischemic stroke, stroke mimics

Significant dose-effect seen between flossing frequency and reduction in incident ischemic stroke

Approval is for those who have had prior therapy for unresectable or metastatic disease

Findings seen for patients with somatic alterations in the PI3K signaling pathway

Benefits seen for oxidative stress markers, inflammatory indices, and liver enzymes